Abstract
99mTc nitrido-Levetiracetam was prepared using the 99mTc nitrido core for labeling. The reaction conditions were optimized to get the highest radiochemical purity (98%): substrate amount 2 mg, Sn(II) (reducing agent) amount 50 µg, pH 7, 30 min, ambient temperature. The biodistribution studies revealed high brain uptake of 99mTc nitride-Levetiracetam, reaching a maximum of 9% ID/g at 30 min post injection (p.i.). The complex deserves further analysis as a candidate brain imaging agent.
Similar content being viewed by others
REFERENCES
Levetiracetam Monograph for Professionals Drugs.com, AHFS, Retrieved Jan. 14, 2019.
Lattanzi, S., Zaccara, G., Giovannelli, F., Grillo, E., Nardone, R., Silvestrini, M., Trinka, E., and Brigo, F., Acta Neurol. Scand., 2019, vol. 139, no. 1, pp. 33–41.
Mbizvo, G.K., Dixon, P., Hutton, J.L., and Marson, A.G., Cochrane Database of Systematic Reviews, 2012, no. 9, CD001901.
Sanad, M.H., Saleh, G.M., and Marzook, F.A., J. Label. Compd. Radiopharm., 2017, vol. 60, pp. 600–607.
Filler, A.F., Int. J. Neurosurg., 2010, vol. 7, no. 1, pp. 1–85.
Sandrone, S., Bacigaluppi, M., Galloni, M.R., Cappa, S.F., Moro, A., Catani, M., Filippi, M., Monti, M.M., Perani, D., and Martino, G., Brain, 2014, vol. 137, no. 2, pp. 621–633.
Peruzzotti-Jametti, L., Bacigaluppi, M., Sandrone, S., and Cambiaghi, M., Neurology, 2013, vol. 80, no. 4, pp. e33–e35.
Martino, G. and Bacigaluppi, M., Cytotherapy, 2011, vol. 13, no. 1, pp. 6–7.
Lynch, B.A., Lambeng, N., Nocka, K., et al., Proc. Natl. Acad. Sci. USA, 2004, vol. 101, no. 26, pp. 9861–9866.
Vogl, C., Mochida, S., Wolff, C., et al., Mol. Pharmacol., 2012, vol. 82, no. 2, pp. 199–208.
Rogawski, M.A., Epilepsy Res., 2006, vol. 69, no. 3, pp. 273–294.
Sanad, M.H., Farouk, N., and Fouzy, A.S.M., Radiochim. Acta, 2017, vol. 105, no. 9, pp. 729–737.
Sanad, M.H. and Alhussein, A.I., Radiochim. Acta, 2018, vol. 106, no. 3, pp. 229–238.
Sanad, M.H., Sallam, Kh.M., and Dina, H.S., Radiochemistry, 2018, vol. 60, no. 1, pp. 58–63.
Zhang, J., Wang, X., and Jin, C., J. Radioanal. Nucl. Chem., 2007, vol. 272, no. 1, pp. 91–94.
Amin, A.M., Sanad, M.H., and Abd-Elhaliem, S.M., Radiochemistry, 2013, vol. 55, no. 6, pp. 624–628.
Erfani, M., Hassanzadeh, L., Ebrahimi, S.E.S., and Shafiei, M., Iran. J. Nucl. Med., 2012, vol. 20, no. 1, pp. 25–31.
Neirinckx, R.D., Canning, L.R., Piper, I.M., Nowotnik, D.P., Pickett, R.D., Holmes, R.A., Volkert, W.A., Forster, A.M., Weisner, P.S., Marriott, J.A., and Chaplin, S.B., J. Nucl. Med., 1987, vol. 28, pp. 191–202.
Walovitch, R.C., Hill, T.C., Garrity, S.T., Cheesman, E.H., Burgess, B.A., O’Leary, D.H., Watson, A.D., Ganey, M.V., Morgan, R.A., and Williams, S.J., J. Nucl. Med., 1989, vol. 30, pp. 1892–1901.
Zhang, J.B., Wang, X.B., and Tian, C.J., J. Radioanal. Nucl. Chem., 2007, vol. 273, no. 1, pp. 15–17.
Ibrahim, I.T. and Sanad, M.H., Radiochemistry, 2013, vol. 55, no. 3, pp. 336–339.
Sanad, M.H., J. Anal. Sci. & Technology, 2014, vol. 5, no. 1, p. 23.
Motaleb, M.A., Adli, A.S.A, El-Tawoosy, M., Sanad, M.H., AbdAllah, M., J. Label Compd. Radiopharm., 2016, vol. 59, pp. 157–163.
He, H., Morley, J.E., Twamley, B., Groeneman, R.H., Bucar, D.K., MacGillivray, L.R., and Benny, P.D., Inorg. Chem., 2009, vol. 48, pp. 10625–10634.
Metter, F.A. and Guiberteau, M.J., Essentials of Muclear Medicine Imaging. Radioactivity, Radionuclides, and Radiopharmaceuticals, Philadelphia: Saunders, 2006.
Sanad, M.H., El-Bayoumy, A.S.A., and Alhussein, I.A., J. Radioanal. Nucl. Chem., 2017, vol. 311, pp. 1–14.
Sanad, M.H. and Emad, H.B., Radiochim. Acta, 2015, vol. 103, pp. 879–891.
Sanad, M.H. and El-Tawoosy, M., Radioanalytical and Nuclear Chemistry, 2013, vol. 298, pp. 1105–1109.
Sanad, M.H. and Challan, S.B., Radiochemistry, 2017, vol. 59, pp. 307–312. https://doi.org/10.1134/S1066362217030158
Sanad, M.H., Salama, D.H., and Marzook, F.A., Radiochim. Acta, 2017, vol. 105, pp. 389–398.
Ebtisam, A.M., Ahmed, S.E., and Fawzy, A.M., J. Radiation Res. & Appl. Sci., 2019, vol. 12, pp. 304–310.
Faheem, A.R., Bokhari, T.H., Roohi, S., Mushtaq, A., and Sohaib, M., J. Nucl. Med. Biol., 2013, vol. 40, p. 148.
Faheem, A.R., Syed, A.R.N., Muhammad, M., Samina, R., Ameer, F.Z., Zulfi qar, A.K., and Rashid, R., J. Chil. Chem. Soc., 2017, vol. 62, p. 3345.
Saleha, T., Syed, F. A. R., and Ummar, A., Biomed. J. Sci. Tech. Res., 2018, pp. 5787–5796. https://doi.org/10.26717/BJSTR.2018.07.001475
Safaa, B. C., Fawzy, A. M., and Ayman M., Radiochimica Acta, 2020, vol. 108, pp. 397–408
Borai, E., Sanad, M.H., and Fouzy, A.S.M., Radiochemistry, 2016, vol. 58, no. 1, pp. 84–91. https://doi.org/10.1134/S1066362216010136
Sanad, M.H. and Ibrahim, I.T., Radiochemistry, 2015, vol. 57, pp. 425–430. https://doi.org/10.1134/S1066362215040165
Amin, A.M., Sanad, M.H., Abd-Elhaliem, S.M., Radiochemistry, 2013, vol. 55, pp. 624–628. https://doi.org/10.1134/S1066362213060118
Sanad, M.H. and Talaat, H.M., Radiochemistry, 2017, vol. 59, pp. 396–401. https://doi.org/10.1134/S1066362217040129
El-Kawy, O.A., Sanad, M.H., Marzook, F., J. Radioanalytical and Nuclear Chemistry, 2016, vol. 301, pp. 279–286.
Sanad, M.H. and Amin, A.M., Radiochemistry, 2013, vol. 55, pp. 521–526. https://doi.org/10.1134/S1066362213050123
ACKNOWLEDGMENTS
I would like to extend my sincere thanks and gratitude to everyone who gave me even a small contribution to accomplish this fruitful work, starting with the authors participating in the this work, as well as my professors, colleagues and students. I would also like to thank my family who created the right conditions for me to do this work, my father, mother, wives, brothers as well as all my children: Mohammed, Menna, Abd-Allah, Hamdi, Mostafa and Maryam Sanad. In addition, this work was supported by STDF–National Research Centre under project number 41535.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sanad, M.H., Eyssa, H.M., Marzook, F.A. et al. Radiosynthesis and Biological Evaluation of 99mTc Nitrido-Levetiracetam as a Brain Imaging Agent. Radiochemistry 63, 635–641 (2021). https://doi.org/10.1134/S106636222105012X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S106636222105012X